Wei‐Ju Su
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Epidemiology 14
- Hepatitis B Virus Studies 7
- Pneumonia and Respiratory Infections 3
- Respiratory viral infections research 3
- Influenza Virus Research Studies 2
-
- Parvovirus B19 Infection Studies 2
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Yuen‐Liang Lai (4 shared papers)Mei‐Hwei Chang (8 shared papers)Hui‐Wen Lin (1 shared paper)Chien‐Kuo Liu (1 shared paper)Yen‐Hsuan Ni (6 shared papers)Huey‐Ling Chen (6 shared papers)Ta‐Chien Chan (2 shared papers)Ping‐Ing Lee (3 shared papers)
- Journals
- The Journal of Infectious Diseases (2 papers)Clinical Infectious Diseases (2 papers)International Journal of Environmental Research and Public Health (1 paper)Journal of Microbiology Immunology and Infection (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- TaiwanSouth KoreaUnited States
In The Last Decade
Wei‐Ju Su
25 papers receiving 456 citations
Peers
Comparison fields: 5 of 61
- Hepatology 68
- Reproductive Medicine 57
- Epidemiology 193
- Obstetrics and Gynecology 29
- Microbiology 24
Countries citing papers authored by Wei‐Ju Su
This map shows the geographic impact of Wei‐Ju Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ju Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ju Su more than expected).
Fields of papers citing papers by Wei‐Ju Su
This network shows the impact of papers produced by Wei‐Ju Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ju Su. The network helps show where Wei‐Ju Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ju Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 138 | |
| 2 | 2016 | 67 | |
| 3 | 2016 | 43 | |
| 4 | 2009 | 38 | |
| 5 | 2012 | 35 | |
| 6 | 2011 | 20 | |
| 7 | 2014 | 19 | |
| 8 | 2020 | 17 | |
| 9 | 2018 | 16 | |
| 10 | 2010 | 13 | |
| 11 | 2021 | 10 | |
| 12 | 2007 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 7 | |
| 16 | Persistent pulmonary hypertension in a neonate with vein of Galen arteriovenous malformation. | 2005 | 5 |
| 17 | 2010 | 4 | |
| 18 | 2010 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2018 | 2 |
About Wei‐Ju Su
Wei‐Ju Su is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Oncology and Immunology, having authored 28 papers that have together received 475 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (7 papers), Pneumonia and Respiratory Infections (3 papers), Respiratory viral infections research (3 papers), Hepatitis Viruses Studies and Epidemiology (2 papers), Parvovirus B19 Infection Studies (2 papers), Influenza Virus Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Hepatology (68 citations), Reproductive Medicine (57 citations), Epidemiology (193 citations), Obstetrics and Gynecology (29 citations) and Microbiology (24 citations). Wei‐Ju Su has collaborated with scholars based in Taiwan, South Korea and United States. Frequent co-authors include Yuen‐Liang Lai, Mei‐Hwei Chang, Hui‐Wen Lin, Chien‐Kuo Liu, Yen‐Hsuan Ni, Huey‐Ling Chen, Ta‐Chien Chan, Ping‐Ing Lee, Chin-Hui Yang and Pei‐Hung Chuang. Their work appears in journals such as The Journal of Infectious Diseases, Clinical Infectious Diseases, International Journal of Environmental Research and Public Health, Journal of Microbiology Immunology and Infection and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.